J. Goldman & CO LP Biomarin Pharmaceutical Inc Put Options Transaction History

J. Goldman & CO LP

  • $3.21 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$74.43 - $92.22 $1.51 Million - $1.87 Million
20,300 New
20,300 $1.67 Million
Q2 2023

Aug 14, 2023
BUY
$86.68 - $100.3 $1.52 Million - $1.76 Million
17,500 New
17,500 $1.52 Million
Q1 2021

May 17, 2021
SELL
$74.73 - $90.69 $6.28 Million - $7.62 Million
-84,000 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$72.61 - $90.2 $6.1 Million - $7.58 Million
84,000 New
84,000 $7.37 Million

Others Institutions Holding BMRN

# of Institutions
637
Shares Held
177M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track J. Goldman & CO LP Portfolio

Follow J. Goldman & CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on J. Goldman & CO LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email